Description
Seeking men and women aged 18-74 with newly diagnosed Acute Myeloid Leukemia (AML) for a study of an investigational drug combination.
Overview
Participants in this study will take two drugs pills. There are 10 study visits over 20 months and participants are asked to keep a diary of when they take their drugs, eat meals, and symptoms they may experience.
What we're hoping for
We are studying whether an investigational drug combination is safe and effective for people newly diagnosed with Acute Myeloid Leukemia (AML)
Additional Information
ClinicalTrials.gov Identifier: NCT04657081